Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at HUF 9.12T, ahead of Eli Lilly (HUF 7.02T) and Merck & Co (HUF 6.21T). Figures as of 19 Nov 2026, 23:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonHUF 9.12T
- Median
- HUF 92.6B
- Combined market value
- HUF 3034.9T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | HUF 43.7B | HUF 1.28T | HUF 5,449.84 | 6.04% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | HUF 42.3B | HUF 1.95T | HUF 97,614.12 | 3.94% down | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | HUF 33.9B | HUF 2.42T | HUF 22,105.55 | 4.15% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | HUF 33.1B | HUF 1.86T | HUF 40,948.67 | 2.03% down | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | HUF 24.5B | HUF 2.54T | HUF 7,276.66 | 2.24% down | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HUF 20.1B | HUF 2.5T | HUF 31,819.67 | 1.59% down | 129% up | ||
| 107 | RepligenRGEN · Health Care | HUF 16.6B | HUF 3.7T | HUF 57,930.96 | 1.38% down | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | HUF 3.3B | HUF 1.73T | HUF 4,538.13 | 3.12% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | HUF 2.5B | HUF 1.47T | HUF 30,685.14 | 1.46% down | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -HUF 554.8M | HUF 2.1T | HUF 14,849.29 | 1.25% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -HUF 2.9B | HUF 3.23T | HUF 21,125.80 | 1.83% down | 44% up | ||
| 112 | RadNetRDNT · Health Care | -HUF 6.3B | HUF 1.86T | HUF 23,646.61 | 3.22% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -HUF 7.9B | HUF 2.12T | HUF 32,491.55 | 3.27% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -HUF 8.7B | HUF 1.58T | HUF 16,431.18 | 3.86% down | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -HUF 14.8B | HUF 2.57T | HUF 19,520.10 | 0.54% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -HUF 20.2B | HUF 1.54T | HUF 9,542.33 | 1.44% down | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -HUF 23.2B | HUF 1.81T | HUF 6,307.12 | 4.92% down | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -HUF 23.8B | HUF 1.79T | HUF 42,316.23 | 0.38% down | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -HUF 26.4B | HUF 2.09T | HUF 51,375.49 | 3.33% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -HUF 26.4B | HUF 2.59T | HUF 37,972.01 | 4.07% down | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -HUF 35.9B | HUF 2.25T | HUF 33,192.34 | 1.91% up | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -HUF 39.7B | HUF 1.33T | HUF 15,182.68 | 2.75% down | 66% up | ||
| 123 | ErascaERAS · Health Care | -HUF 42.4B | HUF 1.7T | HUF 4,837.50 | 3.34% up | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -HUF 44.3B | HUF 2.75T | HUF 42,190.36 | 2.47% down | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -HUF 49.1B | HUF 5.35T | HUF 111,558.51 | 1.60% down | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -HUF 52.8B | HUF 3.15T | HUF 33,212.75 | 3.77% down | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -HUF 54.8B | HUF 2.49T | HUF 27,861.56 | 2.38% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -HUF 55.2B | HUF 1.63T | HUF 28,858.32 | 1.01% up | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -HUF 57.1B | HUF 1.53T | HUF 14,005.62 | 0.48% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -HUF 62.3B | HUF 2.43T | HUF 46,156.98 | 1.25% up | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -HUF 62.5B | HUF 1.37T | HUF 10,028.80 | 1.24% up | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -HUF 63.9B | HUF 4.79T | HUF 80,999.24 | 2.15% up | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -HUF 66.9B | HUF 2.75T | HUF 39,734.19 | 1.88% down | 18% up | ||
| 134 | NateraNTRA · Health Care | -HUF 70.8B | HUF 14.3T | HUF 98,627.88 | 0.15% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -HUF 78.2B | HUF 2.18T | HUF 33,304.60 | 0.09% up | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -HUF 78.9B | HUF 4.47T | HUF 8,943.60 | 1.54% down | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -HUF 82.5B | HUF 1.73T | HUF 31,321.29 | 2.61% down | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -HUF 86.1B | HUF 5.71T | HUF 87,075.03 | 5.32% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -HUF 98.1B | HUF 3.14T | HUF 134,966.98 | 0.34% down | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -HUF 101B | HUF 1.06T | HUF 5,477.06 | 0.92% down | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -HUF 102B | HUF 9.6T | HUF 13,253.80 | 0.59% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -HUF 103.2B | HUF 2.96T | HUF 105,765.07 | 1.87% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -HUF 105.9B | HUF 3.47T | HUF 40,615.28 | 1.44% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -HUF 111.9B | HUF 1.64T | HUF 9,436.87 | 0.25% down | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -HUF 113.3B | HUF 1.56T | HUF 5,531.49 | 4.30% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -HUF 119.5B | HUF 2.38T | HUF 2,235.05 | 1.94% down | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -HUF 121.2B | HUF 5.16T | HUF 80,437.93 | 4.57% down | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -HUF 122.5B | HUF 2.52T | HUF 7,038.53 | 1.24% down | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -HUF 126.9B | HUF 2.4T | HUF 27,436.32 | 3.79% down | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -HUF 128.6B | HUF 2.09T | HUF 17,135.37 | 4.94% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -HUF 129.7B | HUF 1.54T | HUF 9,259.97 | 0.62% down | 63% down | ||
| 152 | GRAILGRAL · Health Care | -HUF 138.9B | HUF 1.6T | HUF 35,665.52 | 2.68% up | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -HUF 141.6B | HUF 6.7T | HUF 49,528.26 | 0.31% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -HUF 150.8B | HUF 2.77T | HUF 8,902.77 | 5.08% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -HUF 172B | HUF 2.29T | HUF 11,062.98 | 1.96% down | 46% up | ||
| 156 | AvantorAVTR · Health Care | -HUF 180.4B | HUF 3.49T | HUF 5,143.67 | 1.63% down | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -HUF 197.9B | HUF 1.28T | HUF 13,243.60 | 3.14% down | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -HUF 249.3B | HUF 5.18T | HUF 26,596.05 | 0.22% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -HUF 260.8B | HUF 3.14T | HUF 19,853.49 | 0.27% down | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -HUF 267B | HUF 2.44T | HUF 17,506.18 | 0.27% up | 19% down | ||
| 161 | TeleflexTFX · Health Care | -HUF 308.1B | HUF 2.2T | HUF 55,587.05 | 1.48% down | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -HUF 324.7B | HUF 23.27T | HUF 7,283.47 | 0.66% up | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -HUF 325.6B | HUF 4.47T | HUF 8,637.42 | 2.94% down | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -HUF 367.3B | HUF 2.88T | HUF 3,595.81 | 0.67% up | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -HUF 384.9B | HUF 11.73T | HUF 54,236.49 | 0.24% down | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -HUF 428.8B | HUF 6.86T | HUF 27,684.66 | 2.26% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -HUF 434.3B | HUF 10.78T | HUF 49,143.85 | 20.58% up | 40% down | ||
| 168 | ModernaMRNA · Health Care | -HUF 960B | HUF 27.44T | HUF 67,810.07 | 1.29% up | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -HUF 1.2T | HUF 7.75T | HUF 6,762.98 | 1.97% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -HUF 2.27T | HUF 11.04T | HUF 22,309.66 | 2.77% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 340.2 HUF).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (HUF 9.12T), Eli Lilly (HUF 7.02T) and Merck & Co (HUF 6.21T) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 23:47 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of HUF 3034.9T as of 19 Nov 2026, 23:47 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.